Alzheimer's disease is the most common cause of dementia, a major form of mental impairment, in older people.
The Southern California
Alzheimer's Disease Diagnostic and Treatment Center provides diagnosis of cognitive impairments, treatment and on-going care for demented patients, and educational programs for professionals and families.
Reportedly, the confirmatory phase 3 study in early
Alzheimer's disease patients will according to Eisai be initiated in March 2019 and the final readout of primary endpoint is targeted for 2022.
*Do you know that
Alzheimer's disease is the most common form of dementia among older people especially in Western countries and Japan?
During that time, 21,451 people developed cancer and 2,832 people developed
Alzheimer's disease.
The researchers found that people with a mother who had
Alzheimer's disease had twice as much gray matter shrinkage as the groups who had a father or no parent with
Alzheimer's disease.
The current management of
Alzheimer's disease is reviewed and it involves a multidisciplinary approach.
Maxim's conference for investors, titled '
Alzheimer's Disease - What's Next Treating Alzheimer's in a Post-Amyloid World', will be held at their corporate offices at 405 Lexington Ave in New York.
According to the Alzheimer's Association, Florida is number one in per capita cases of
Alzheimer's disease in the U.S.
This phase 3 study (named Clarity AD/Study 301) that is now initiated is a global placebo-controlled, double-blind, parallel-group, randomised study in 1566 patients with early
Alzheimer's disease, such as mild cognitive impairment (MCI) due to
Alzheimer's disease or mild
Alzheimer's disease with confirmed amyloid pathology in the brain.
Reportedly, BioArctic has a strategic research collaboration with Eisai regarding BAN2401 in
Alzheimer's disease, a separate drug candidate with positive results in a phase 2b study.
"Decades of research have revealed common processes that are relevant to understanding why the aging brain is vulnerable to
Alzheimer's disease. New therapeutics for
Alzheimer's disease will come from this understanding of the effects of aging on the brain."
For individuals carrying a genetic mutation that causes AD, engaging in at least 2.5 hours of physical activity per week may have beneficial effects on markers of
Alzheimer's disease brain changes and may delay cognitive decline.
Viruses may play a role in
Alzheimer's disease. Analysis of large data sets from post-mortem brain samples of people with and without
Alzheimer's disease has revealed new evidence that viral species, particularly herpesviruses, may have a role in
Alzheimer's disease biology.
Many people are also misinformed that
Alzheimer's disease hits only elderly people.
